Clinical Trials

Hush now: New gene-silencing drug cuts cholesterol by half in clinical trial

Why it matters to you<p>Fighting cholesterol can be tricky, but this new drug targets the condition at its source.<p>Nearly 32 percent of adults in the …

Medicine

Is Now Too Soon To Buy Adaptimmune?

Recent offering at $4.20 will raise 60 million dollars.<p>Consensus of 6 analysts' one-year target is $14.23.<p>Key alliances with M.D. Anderson, Merck, …

Cancer

MS Toolset for Measuring Clinical Trial Outcomes Supported by Research Group

Four newly published articles, the focused work of a group of researchers, evaluate the validity of four outcome measures commonly used in clinical …

Medicine

Treatment of Major Depressive Disorder with Iyengar Yoga and Coherent Breathing: A Randomized Controlled Dosing Study. - PubMed

OBJECTIVES:<p>The aims of this study were to assess the effects of an intervention of Iyengar yoga and coherent breathing at five breaths per minute on …

Depression

Xenon Dumps Acne Drug After Study Failure (XENE)

Xenon Pharmaceuticals Inc. (XENE) announced that its acne drug XEN801, intended for moderate-to-severe facial acne, failed a Phase 2 clinical study. …

Medicine

Aurinia Pharmaceuticals: Fully Funded With Upcoming Catalysts

After recently raising an additional $173 million in equity financing, Aurinia is fully funded to complete its Phase 3 AURORA trial for voclosporin …

Investing

Researching the researchers: meet Stanford school's 'Cassandra' of fake news

John Ioannidis is worried about the rise of false data in science - so he studies the studies<p>How much of science is truly accurate, and how much should we distrust? John Ioannidis, professor of disease prevention at the Stanford School of Medicine, spends his time trying to answer these questions - …

Research

European regulators 'didn't even read' risk studies on Monsanto pesticide glyphosate

German and European regulators never undertook a critical assessment of the cancer risks of the herbicide active agent, glyphosate. That's the view of environmental chemist Dr Helmut Burtscher.<p><i>DW: Dr. Burtscher, your initiative "Global 2000" has published a study into the approval process for the</i> …

Agriculture

The Government Just Funded The Biggest Long-Term Study Of Black Cancer Survivors

It's about time.<p>The National Institutes of Health recently announced that it will fund the largest-ever study of African-American cancer survivors. The agency is providing a five-year, $9 million grant for the Detroit Research on Cancer Survivors study, which will look at 5,560 black Americans who …

Cancer

Pushing Immunotherapies Toward the Frontline in Bladder Cancer

Immunotherapy treatments for several tumor types has been developing steadily for years. However, the options for patients with bladder cancer have …

Cancer

Buy Ophthotech, Get Cash And Zimura For Free

OPHT is an unloved, micro-cap stock trading at more than 20% below its net operating cash, with a restructured burn rate which prevents significant …

Stocks

Five startups working to modernize clinical trials

Clinical trials are a massive, often global undertaking that can suck up years and tens of millions of dollars. The good news? There are plenty of …

Health Care

Novartis Heart Medicine Fails in Late-Stage Clinical Trial - Bloomberg

Novartis AG said an experimental drug for acute heart failure didn’t meet the goals in a late-stage clinical trial, dashing the hopes for a medicine …

Medicine

Halozyme: Exploring The Potential Of PEGPH20

PEGPH20 has great potential in Hyaluronan (HA) positive Metastatic Pancreatic Cancer.<p>There are ongoing and upcoming trials of PEGPH20.<p>The market …

Cancer

Marinus Pharmaceuticals: Will Ganaxolone Succeed This Time?

Ganaxolone has had many failures in phase 3 trials.<p>Its two latest phase 2 trials were quite successful on small patient populations.<p>If it succeeds, …

Medicine

BioLineRX: Update And Preview Of The Company's Q4 And FY 2016 Financial Results On March 23, 2017

The company reported positive Phase 2 stem-cell mobilization results for its lead drug candidate BL-8040 on March 20, 2017.<p>The March 20, 2017, …

Investing

Who Weighs the Risk of Right-to-Try Drugs?

In his March 14 op-ed “On ‘Right to Try,’ the FDA Should Proceed With Caution,” Henry Miller recognizes that the “slow, dysfunctional agency [FDA] needs drastic reform of its requirements, procedures and attitudes,” so his hesitance on right-to-try, the bipartisan national movement to aid those in …

Medicine

For Rare Disease Patients, A Pathway To Hundreds Of New Therapies

Many rare disease patients use drugs off-label based on limited data because they have no better options available. In fact, it is estimated that 95 …

Health Care

A stem cell clinical trial for blindness: watch Rosie’s story

Everything we do at CIRM is laser-focused on our mission: to accelerate stem cell treatments for patients with unmet medical needs. So, you might …

Medicine

Phase 1/2 Clinical Trial of Apexigen's APX005M in Combination with Pembrolizumab (Keytruda®) Opens for Metastatic Melanoma Patients

SAN CARLOS, Calif., March 21, 2017 /PRNewswire/ -- Apexigen, Inc., a clinical-stage biopharmaceutical company focusing on discovering and developing …

Cancer

Major pancreatic cancer study launched

<b>A new pancreatic cancer project has been launched to find ways to speed up scientific discovery to improve the survival rates of patients.</b><p>Cancer Research have invested £10m in the PRECISION-Panc project, which aims to find quick ways of finding the right treatment for individual tumours.<p>Researchers …

Cancer

Inotek Pharmaceuticals Could Be Getting A Second Chance

Trabodenoson did not achieve statistically significant results in their monotherapy trial in January 2017.<p>Reason for failure is being contributed to …

Stocks

Biz Break: No pain for Nektar in wake of latest clinical trial success

<b>Top of the Order:</b><p><b>Pain? No Pain:</b> In the Bay Area, all you have to do is walk out of your front door and you’ll trip over a tech company of some sort …

Medicine

Mother hopes child is picked for cannabis oil trials

Harper Grace is the namesake of Mississippi's Harper Grace's Law adopted in 2014, but that's no guarantee she'll be chosen for the canabis oil trials …

Marijuana

China proposes new FDA rules to speed up foreign drug approvals

Now it’s clear that when China’s FDA director Bi Jingquan promised to speed up foreign drug approvals in China a few days ago during the country’s …

China

The More Widely Cited A Study Is, The More Likely It Is To Exaggerate, Says This Study

A major analysis of bias in science has found that small studies, early studies and highly cited studies consistently overstate the effects they find.<p>Scientific studies which are cited by lots of other papers are more likely to show evidence of bias, according to new research.<p>Small studies, the …

Research

RedHill Biopharma: Multiple Drugs In Advanced Phase III Development Provide Substantial Upside

RedHill Biopharma is an undervalued biotech company focused on treating GI diseases, including Crohn's; inflammatory diseases; and cancer.<p>RedHill has …

Investing

Omeros: An Upbeat Prognosis

Small-cap biotech concern Omeros just reported quarterly results.<p>The company made progress increasing sales of its one approved drug "Omidria" as …

Investing

A pricey drug cuts cardiovascular risks in clinical trial — but will insurers cover it?

A drug succeeded in lowering cardiovascular risks in a clinical trial, but questions remain over whether insurers will cover it. Photo by RunPhoto …

Investing

Getting It Wrong on Chronic Fatigue Syndrome

What are some of the treatment regimens that sufferers of chronic fatigue syndrome should follow? Many major medical organizations cite two: psychotherapy and a steady increase in exercise. There’s just one problem. The main study that has been cited as proof that patients can recover with those …

Medicine